Clinical trial
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
NCT01770964 is registered in ClinicalTrials.gov with Analgesic Solutions as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN)
- Lead sponsor
- Analgesic Solutions
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2012
- Completion date
- July 31, 2013
- Enrollment
- 90 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, painful distal symmetric sensorimotor polyneuropathy